ClinicalTrials.Veeva

Menu

Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation (iRead)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Atrial Flutter
Atrial Fibrillation

Treatments

Device: Record and transmit heart rhythm

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm

Full description

AliveCor is a new monitoring technology used with a smart phone which allows patients to record their rhythm. The study will compare AliveCor recordings and automated interpretation of the rhythm with the interpretation by an Electrophysiologist.

Enrollment

60 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female between > 18 and < 80 years of age
  2. Paroxysmal or persistent atrial fibrillation
  3. Admitted for antiarrhythmic drug loading (Dofetilide or Sotalol)
  4. Already has iPhone 4, 4S or 5 with data plan that accommodates the AliveCor case
  5. Willing to use the Alive Cor case
  6. Written informed consent

Exclusion criteria

  1. Unable or unwilling to use the Alive Cor case for their smart phone
  2. Presence of a permanent pacemaker

Trial design

60 participants in 1 patient group

Patients with Atrial Fibrillation
Description:
Patients with Atrial Fibrillation admitted to the hospital for drug loading with Dofetilide or Sotalol willing to record and transmit heart rhythm using AliveCor.
Treatment:
Device: Record and transmit heart rhythm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems